These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38522053)
21. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre. Voona S; Abdic H; Montgomery R; Clarkson A; Twitchell H; Hills T; Briggs S; Crooks C; Monaghan TM Anaerobe; 2022 Feb; 73():102479. PubMed ID: 34801705 [TBL] [Abstract][Full Text] [Related]
22. Health care associated Clostridioides difficile infection and colonization in patients admitted at tertiary care hospital Pakistan. Ahmed A; Ikram A; Sabir N; Zaman G; Gardeezi A; Satti L J Pak Med Assoc; 2022 Apr; 72(4):610-615. PubMed ID: 35614587 [TBL] [Abstract][Full Text] [Related]
23. Severe Páramo-Zunzunegui J; Ortega-Fernández I; Calvo-Espino P; Diego-Hernández C; Ariza-Ibarra I; Otazu-Canals L; Danés-Grases JE; Menchero-Sánchez A Ann R Coll Surg Engl; 2020 Sep; 102(7):e176-e179. PubMed ID: 32803988 [TBL] [Abstract][Full Text] [Related]
24. Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review. Abadi B; Ilaghi M; Shahsavani Y; Faramarzpour M; Oghazian MB; Rahimi HR Curr Rev Clin Exp Pharmacol; 2023; 18(1):51-63. PubMed ID: 34994339 [TBL] [Abstract][Full Text] [Related]
25. Healthcare-associated Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203 [No Abstract] [Full Text] [Related]
26. Case report of SARS-CoV-2 with secondary Clostridioides difficile infection. Batra P; Khullar S; Choudhary M; Saikiran KVP; Kaginalkar A; Singh S; Mohan A; Chaudhry R Indian J Med Microbiol; 2023; 45():100356. PubMed ID: 37573046 [TBL] [Abstract][Full Text] [Related]
27. Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report. Jing R; Vunnam RR; Schnaubelt E; Vokoun C; Cushman-Vokoun A; Goldner D; Vunnam SR BMC Infect Dis; 2021 Jan; 21(1):68. PubMed ID: 33441085 [TBL] [Abstract][Full Text] [Related]
28. Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Stămăteanu LO; Miftode IL; Pleșca CE; Dorneanu OS; Roșu MF; Miftode ID; Obreja M; Miftode EG Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508187 [TBL] [Abstract][Full Text] [Related]
29. Hospital-onset Luo Y; Grinspan LT; Fu Y; Adams-Sommer V; Willey DK; Patel G; Grinspan AM Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1165-1166. PubMed ID: 32962772 [No Abstract] [Full Text] [Related]
30. Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania. Marinescu AR; Laza R; Musta VF; Cut TG; Dumache R; Tudor A; Porosnicu M; Lazureanu VE; Licker M Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684136 [No Abstract] [Full Text] [Related]
31. Clostridioides difficile infection during the COVID-19 pandemic: a gut microbiota-based relationship. Cammarota G; Giambò F; Ianiro G Pol Arch Intern Med; 2021 Feb; 131(2):116-117. PubMed ID: 33641317 [No Abstract] [Full Text] [Related]
32. Outcomes in Patients with SARS-CoV-2 and Sehgal K; Fadel HJ; Tande AJ; Pardi DS; Khanna S Infect Drug Resist; 2021; 14():1645-1648. PubMed ID: 33953575 [TBL] [Abstract][Full Text] [Related]
33. [Study on the features of Li GM; Gu WP; Hou M; Jia SQ; Wang YY; Bai LL; Yin JW; Zhou YM; Fu XQ; Lu JX; Wu Y Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Apr; 44(4):624-628. PubMed ID: 37147836 [No Abstract] [Full Text] [Related]
34. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea. Abad CLR; Safdar N Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444 [TBL] [Abstract][Full Text] [Related]
37. A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021). Lanzas C; Jara M; Tucker R; Curtis S; Anaerobe; 2022 Apr; 74():102541. PubMed ID: 35217149 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy. Maziade PJ; Ship N; Sniffen JC; Goldstein EJC Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076 [TBL] [Abstract][Full Text] [Related]
39. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Bentivegna E; Alessio G; Spuntarelli V; Luciani M; Santino I; Simmaco M; Martelletti P Am J Infect Control; 2021 May; 49(5):640-642. PubMed ID: 33031863 [TBL] [Abstract][Full Text] [Related]
40. Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19: A Review. Linares-García L; Cárdenas-Barragán ME; Hernández-Ceballos W; Pérez-Solano CS; Morales-Guzmán AS; Miller DS; Schmulson M J Clin Gastroenterol; 2022 Apr; 56(4):285-298. PubMed ID: 35125404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]